buagafuran capsule
/ Beijing Union Pharmaceutical Factory
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
September 16, 2026
Extended Observational Study Following Fixed-Dose Treatment with Buagafuran Capsule in Generalized Anxiety Disorder
(ChiCTR)
- P=N/A | N=504 | Not yet recruiting | Sponsor: Beijing Anding Hospital Affiliated to Capital Medical University; Beijing Anding Hospital Affiliated to Capital Medical University
New trial • CNS Disorders • General Anxiety Disorder • Mood Disorders • Movement Disorders • Psychiatry
March 10, 2026
Pharmacokinetic Study of Buagafuran Capsules in Participants With Hepatic Impairment and Normal Hepatic Function
(clinicaltrials.gov)
- P1 | N=24 | Not yet recruiting | Sponsor: Beijing Union Pharmaceutical Factory Ltd
New P1 trial • CNS Disorders • General Anxiety Disorder • Hepatology • Mood Disorders • Psychiatry
March 10, 2026
Study on the Drug Interaction Between Buagafuran and Voriconazole
(clinicaltrials.gov)
- P1 | N=18 | Not yet recruiting | Sponsor: Beijing Union Pharmaceutical Factory Ltd
New P1 trial
February 16, 2024
BGFN-2022-01: Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD
(clinicaltrials.gov)
- P3 | N=410 | Recruiting | Sponsor: Beijing Union Pharmaceutical Factory Ltd
New P3 trial • CNS Disorders • General Anxiety Disorder • Mood Disorders • Psychiatry
February 16, 2024
BGFN-2022-02: Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD
(clinicaltrials.gov)
- P3 | N=504 | Recruiting | Sponsor: Beijing Union Pharmaceutical Factory Ltd
New P3 trial • CNS Disorders • General Anxiety Disorder • Mood Disorders • Psychiatry
1 to 5
Of
5
Go to page
1